Twist Bioscience specializes in the synthesis of synthetic DNA, which is essential for various applications in biotechnology, pharmaceuticals, and research. Their proprietary platform allows for the rapid and accurate production of DNA sequences, providing clients with instant feedback on the synthesizability of their desired sequences. Twist offers a variety of products, including genes, oligo pools, variant libraries, and tools for SARS-CoV-2, as well as DNA data storage and next-generation sequencing services. What sets Twist apart from competitors is their ability to deliver high-quality DNA sequences at competitive prices and their capacity to handle complex DNA sequences that are challenging to synthesize. The company's goal is to support advancements in personalized medicine and genetic research by providing accessible and reliable synthetic DNA solutions.

Biomatics Capital Partners

Reinet Investments S.C.A.

3W Partners

Silicon Valley Bank

+ND Capital

Asset Management Ventures

Tao Venture Partners

Paladin Capital Group

ARCH Venture Partners

Illumina

Foresite Capital

Joby Pritzker

Boris Nikolic

Cormorant Asset Management

ARCH Overage Fund

Illumina Ventures

WuXi Healthcare Ventures

Dentsu Ventures

Biotechnology

Healthcare

Twist Bioscience

Absci, a pioneer in generative AI-driven drug discovery, and Twist Bioscience, a leader in high-quality synthetic DNA production through its silicon platform, have announced an innovative collaboration to create a novel therapeutic antibody using generative AI.

Absci and Twist Bioscience Team Up to Redefine Antibody Discovery with AI

Twist Bioscience teams up with MedGenome to diagnose rare diseases.

Twist Bioscience teams up with MedGenome to diagnose rare diseases

Twist Bioscience Corporation (NASDAQ:TWST), a company at the forefront of DNA synthesis technology, has recently announced its collaboration with bitBiome Inc. to release a new Transaminase Enzyme Screening Kit.

Twist Bioscience and bitBiome launch enzyme screening kit

Twist Bioscience named a Best Idea for 2025 at TD Cowen.

Twist Bioscience named a Best Idea for 2025 at TD Cowen

SOUTH SAN FRANCISCO, Calif.-(BUSINESS WIRE)-
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the appointment of Mike Fero, Ph.D., as chief information officer.

Twist Bioscience Appoints Mike Fero, Ph.D., as Chief Information Officer

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced it has entered into a royalty purchase agreement with XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator.

Twist Bioscience Enters into Royalty Purchase Agreement with XOMA Royalty for $15 Million in Cash

In other recent news, Twist Bioscience has secured a $15 million capital boost from a new financial agreement with XOMA Royalty Corporation.

Twist Bioscience president sells $97,428 in stock

Twist Bioscience expands high-throughput IgG antibody portfolio with launch of CHO Express Antibodies.

Twist Bioscience Expands High-Throughput IgG Antibody Portfolio with Launch of CHO Express Antibodies

Twist Bioscience launches synthetic RNA control for H5N1 Influenza A.

Twist Bioscience Launches Synthetic RNA Control for H5N1 Influenza A

Evolving Data StorageRecording data was crucial to civilization's founding. In fact, the invention of written records defined the separation between the prehistorical and historical periods. From early cuneiform clay tablets and papyrus scrolls to medieval books and the printing press, improvements in writing methods and technology have been transformative to human societies.Today, we record and handle more data than ever. But paradoxically, our storage mediums have become increasingly fragile. For example, we are now aware of disk rot, or CD rot, which is the degradation of the reflective layer of a compact disc (CD). It is likely that most of these storage devices, including museum archives, will be unreadable after mere decades. The same problem affects other optical storage methods like DVDs and Blu-rays.Similarly, hard drives can be very sensitive to electromagnetic waves, so most of the world's data could be erased by a sufficiently strong solar storm or EMP.So overall, compared to manuscripts written on vellum, papyrus, or clay, modern knowledge is just going to last a few decades or a century, or is one catastrophe away from total destruction.Luckily, researchers are exploring technologies for much more durable data storage. And amusingly enough, it might look a lot like the type of crystal we see in alien ships in science-fiction shows.Crystals’ DurabilityMost materials degrade in time, whether it be advanced engraving on silicon wafers or paper/animal skins

Ingenious Storage Mediums – How Crystals Can Save Mankind

Produces synthetic DNA for biotechnology applications

Twist Bioscience

Produces synthetic DNA for biotechnology applications

Twist Bioscience

Produces synthetic DNA for biotechnology applications

About

Simplify's Take

What believers are saying

What critics are saying

What makes Twist Bioscience unique

6 month growth

1 year growth

2 year growth

Benefits

Recently Posted Jobs

Twist Bioscience is Hiring for 0 Jobs on Simplify!